Abstract
Poorly differentiated thyroid carcinoma (PDTC) is a rare malignancy, accounting for 0.3–6.7% of all thyroid cancers. The age at presentation is between 18 and 63 years, with a slight female predilection. It has an aggressive clinical behavior intermediate between that of the well-differentiated thyroid carcinomas and undifferentiated (anaplastic) thyroid carcinoma. PDTC is a thyroid carcinoma of follicular cell origin characterized by an insular, solid, or trabecular growth pattern. The most classic form of PDTC is the insular type, defined by its cellular nests or insular cell groups outlined by a thin fibrovascular border. Cytologically, PDTCs are difficult to recognize as such because they are rare; their cytomorphologic features overlap with those of follicular neoplasms; and their characteristic FNA features do not have great specificity. The tumor cells are positive for keratins, thyroglobulin, TTF-1, and PAX8. Because of their poor clinical prognosis, PDTCs are usually managed more aggressively than well-differentiated thyroid carcinomas, and treatment may include consideration of postoperative 131I therapy.
References
Carcangiu ML, Zampi G, Rosai J. Poorly differentiated (“insular”) thyroid carcinoma. A reinterpretation of Langhans’ “wuchernde struma”. Am J Surg Pathol. 1984;8(9):655–68.
Langhans T. Uber die epithelialen formen der malignen struma. Virchows Arch (A). 1907;189:69–188.
Sobrinho Simoes M, Albores-Saavedra J, Tallini G, et al. Poorly differentiated carcinoma. In: DeLellis R, Lloyd RV, Heitz PU, Eng C, editors. World Health Organization classification of tumours: pathology and genetics of tumours of endocrine organs. Lyon: IARC Press; 2004.
Volante M, Landolfi S, Chiusa L, et al. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients. Cancer. 2004;100(5):950–7.
Bai S, Baloch ZW, Samulski TD, Montone KT, LiVolsi VA. Poorly differentiated oncocytic (Hürthle cell) follicular carcinoma: an institutional experience. Endocr Pathol. 2015;26(2):164–9.
Dettmer M, Schmitt A, Steinert H, Moch H, Komminoth P, Perren A. Poorly differentiated oncocytic thyroid carcinoma – diagnostic implications and outcome. Histopathology. 2012;60(7):1045–51.
Decaussin M, Bernard MH, Adeleine P, et al. Thyroid carcinomas with distant metastases: a review of 111 cases with emphasis on the prognostic significance of an insular component. Am J Surg Pathol. 2002;26(8):1007–15.
Bedrossian CWM, Martinez F, Silverberg AB. Fine needle aspiration. In: Gnepp DR, editor. Pathology of the head and neck. New York: Churchill Livingstone; 1988. p. 25–99.
Flynn SD, Forman BH, Stewart AF, et al. Poorly differentiated (“insular”) carcinoma of the thyroid gland: an aggressive subset of differentiated thyroid neoplasms. Surgery. 1988;104(6):963–70.
Pietribiasi F, Sapino A, Papotti M, et al. Cytologic features of poorly differentiated ‘insular’ carcinoma of the thyroid, as revealed by fine-needle aspiration biopsy. Am J Clin Pathol. 1990;94:687–92.
Sironi M, Collini P, Cantaboni A. Fine needle aspiration cytology of insular thyroid carcinoma: a report of four cases. Acta Cytol. 1992;36:435–9.
Guiter GE, Auger M, Ali SZ, et al. Cytopathology of insular carcinoma of the thyroid. Cancer Cytopathol. 1999;87:196–202.
Nguyen GK, Akin M-RM. Cytopathology of insular carcinoma of the thyroid. Diagn Cytopathol. 2001;25:325–30.
Oertel YC, Miyahara-Felipe L. Cytologic features of insular carcinoma of the thyroid: a case report. Diagn Cytopathol. 2006;34(8):572–5.
Zakowski MF, Schlesinger K, Mizrachi HH. Cytologic features of poorly differentiated “insular” carcinoma of the thyroid. A case report. Acta Cytol. 1992;36(4):523–6.
Barwad A, et al. Fine needle aspiration cytology of insular carcinoma of thyroid. Diagn Cytopathol. 2012;40(Suppl 1):E43–7.
Kane SV, Sharma TP. Cytologic diagnostic approach to poorly differentiated thyroid carcinoma: a single-institution study. Cancer Cytopathol. 2015;123(2):82–91.
Purkait S, et al. Fine needle aspiration cytology features of poorly differentiated thyroid carcinoma. Cytopathology. 2016;27(3):176–84.
Bongiovanni M, Bloom L, Krane JF, et al. Cytomorphologic features of poorly differentiated thyroid carcinoma. A multi-institutional analysis of 40 cases. Cancer Cytopathol. 2009;117(3):185–94.
Nonaka D, Tang Y, Chiriboga L, et al. Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms. Mod Pathol. 2008;21(2):192–200.
Xu B, Ghossein R. Genomic landscape of poorly differentiated and anaplastic thyroid carcinoma. Endocr Pathol. 2016;27(3):205–12.
Sanders EM Jr, LiVolsi VA, Brierley J, et al. An evidence-based review of poorly differentiated thyroid cancer. World J Surg. 2007;31(5):934–45.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Bongiovanni, M., Fadda, G., Faquin, W.C. (2018). Poorly Differentiated Thyroid Carcinoma. In: Ali, S., Cibas, E. (eds) The Bethesda System for Reporting Thyroid Cytopathology. Springer, Cham. https://doi.org/10.1007/978-3-319-60570-8_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-60570-8_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-60569-2
Online ISBN: 978-3-319-60570-8
eBook Packages: MedicineMedicine (R0)